Staying Sexy Without GenAI or Saas—Buiding Deceptively-Simple, but Brilliant Products

Join Catherine Mohr (Intuitive), Rui Jing Jiang (Avisi Technologies), Sydney Robinson, and James Stone (Cannulight Technology) as they discuss how medtech innovation can thrive with brilliantly simple product design, without relying on GenAI or SaaS solutions. For more information watch this video:

Balancing Act: How Do Investors Weigh Founders Versus Markets in Medtech and Healthtech Venture?

With respect to the risks that investors evaluate in their process, some can be deal breakers, as they will almost always kneecap a company’s potential to generate significant financial returns. For example, Dr. Luc Marengere, Managing Partner at TVM Capital, explained that investing in “a so-so” or non-differentiated product “would be very unlikely due to concerns about how to build value in a timely fashion and grab enough market share to drive sufficient value at the time of exit.” This blog is originally published here: https://shorturl.at/Gydyy

Growth in Spain’s Medtech Market: Key Insights from LSI’s Global Surgical Procedure Volumes Database

Stereotactic Radiosurgery, non-invasive intervention that applies focused radiation beams to treat tumors and other abnormalities in the brain and body, is one of the fastest-growing segments in Spain’s medtech market. LSI’s medtech market Intelligence teams projects a compound annual growth rate (CAGR) for SRS procedures at 6.4% from 2023 to 2030. Within this segment, the following sub-segments are experiencing the most rapid growth. This blog is originally published here: https://shorturl.at/Qp9RS

The Memo: Medcura Bringing the Future of Bleeding Control to Spine Surgery

Buck’s path to Medcura began in 2018, when the company’s board approached him with a clear vision: replicate the playbook and success he had at Closure Medical, a biosurgery startup he helped lead to a ~$370 million acquisition by Johnson & Johnson. At the time, Medcura had already shown promising results for its biopolymer platform in trauma and topical care. The next step was to adapt it for internal surgical use, a much larger and more complex market. This blog is originally published here: https://shorturl.at/MkFbf

The Weekly Recap 7/11/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

Received FDA approval to initiate the MOCA-II IDE pivotal trial evaluating its CoFI system for real-time detection of microvascular obstruction (MVO) during primary PCI procedures. The study will enroll over 200 STEMI patients in the U.S. and Europe, advancing efforts to address a major unmet need in heart attack care. This blog is originally published here: https://shorturl.at/ULUdv